A case report of COVID-19 in a patient with non-Hodgkin's lymphoma

BMC Infect Dis. 2021 Aug 12;21(1):809. doi: 10.1186/s12879-021-06472-2.

Abstract

Background: The current literature is scarce as to the outcomes of COVID-19 infection in non-Hodgkin's lymphoma patients and whether immunosuppressive or chemotherapeutic agents can cause worsening of the patients' condition during COVID-19 infection.

Case presentation: Our case is a 59-year-old gentleman who presented to the Emergency Department of the Cancer Institute of Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil on 10th May 2020 with a worsening dyspnea and chest pain which had started 3 days prior to presentation to the Emergency Department. He had a past history of non-Hodgkin's lymphoma for which he was receiving chemotherapy. Subsequent PCR testing demonstrated that our patient was SARS-CoV-2 positive.

Conclusion: In this report, we show a patient with non-Hodgkin lymphoma in the middle of chemotherapy, presented a mild clinical course of COVID-19 infection.

Keywords: COVID; Immunosuppressed; Lymphoma.

Publication types

  • Case Reports

MeSH terms

  • Brazil
  • COVID-19*
  • Humans
  • Immunosuppressive Agents
  • Lymphoma, Non-Hodgkin* / complications
  • Lymphoma, Non-Hodgkin* / drug therapy
  • Male
  • Middle Aged
  • SARS-CoV-2

Substances

  • Immunosuppressive Agents